ES2555257T3 - Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales - Google Patents

Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales Download PDF

Info

Publication number
ES2555257T3
ES2555257T3 ES11712054.3T ES11712054T ES2555257T3 ES 2555257 T3 ES2555257 T3 ES 2555257T3 ES 11712054 T ES11712054 T ES 11712054T ES 2555257 T3 ES2555257 T3 ES 2555257T3
Authority
ES
Spain
Prior art keywords
protein
amino acids
infant formula
essential amino
formula low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11712054.3T
Other languages
English (en)
Other versions
ES2555257T5 (es
Inventor
Johannes Bernard Van Goudoever
Eline Marleen Van Der Beek
Marieke Abrahamse-Berkeveld
Günther Boehm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43216285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2555257(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of ES2555257T3 publication Critical patent/ES2555257T3/es
Application granted granted Critical
Publication of ES2555257T5 publication Critical patent/ES2555257T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0626—Isoleucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0628—Leucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0654—Valine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dairy Products (AREA)

Abstract

Fórmula infantil que comprende proteínas, carbohidratos digeribles y grasas, donde la proteína comprende aminoácidos de leucina, isoleucina y valina en una proporción en peso leucina:isoleucina:valina entre (1,1-1,5):(0,9- 1,1):1,0, y donde el contenido de proteína es entre 1,3 y 1,9 g proteína/100 kcal.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
L-VALINA 109,7 mg L-ASPARAGINA 0 mg L-CITRULINA 0 mg L-CARNITINA 1,2 mg
Ejemplo 4. Fórmula infantil que comprende aminoácidos de proteínas de leche intactas según la invención.
[0062] COMPONENTE UNIDAD Por 100 kcal
1.
Proteínas (equivalente) g 1,4
2.
Carbohidratos g 11,7
- Azúcares g 11,5
3. Grasas g 5,12
- Saturadas g 2,22
4.
Fibra, dietética g 0,856
5.
Sodio g 25,8
5
D. Propiedades nutricionales
Porcentajes de energía: 10 [0063]
1. Proteínas (equivalente) En%
5,6
2. Carbohidratos
En% 46,4 *
3. Grasas
En% 46,3
4. Fibra
En% 1,7
Total
En% 100
* Incluyendo ácidos orgánicos y polioles
15
E. Composición [0064]
1. Proteínas (equivalente), total
g 1,4
20
- Nitrógeno (Proteína) - Proteína animal g g 0,224 1,428
Proteína de suero de leche
g 0,861
13
imagen12
[0065]
L-Alanina
mg 65,8
L-Arginina mg 46,9
Ácido L-Aspártico / L-mg 116,2
Asparagina
L-Cist(e)ina mg 25,2
Ácido L-Glutámico / L-mg 263,2
Glutamina
Glicina mg 29,4
L-Histidine mg 33,6
L-Isoleucina mg 109,7 (84,7 de proteína)
L-Leucina mg 158,2
L-Lisina mg 136,5
L-Metionina mg 37,1
L-Fenilalanina mg 63,7
L-Prolina mg 110,6
L-Serina mg 86,8
L-Treonina mg 86,8
L-Triptófano mg 23,1
L-Tirosina mg 59,5
L-Valina mg 114.6
(89,6 de proteínas) proporción leucina:isoleucina:valina=1,4:1,0:1,0
15

Claims (1)

  1. imagen1
ES11712054T 2010-03-26 2011-03-25 Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales Active ES2555257T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/NL2010/050156 2010-03-26
PCT/NL2010/050156 WO2011119023A1 (en) 2010-03-26 2010-03-26 Low protein infant formula with increased essential amino acids
PCT/NL2011/050207 WO2011119033A1 (en) 2010-03-26 2011-03-25 Low protein infant formula with increased essential amino acids

Publications (2)

Publication Number Publication Date
ES2555257T3 true ES2555257T3 (es) 2015-12-30
ES2555257T5 ES2555257T5 (es) 2022-02-25

Family

ID=43216285

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11712054T Active ES2555257T5 (es) 2010-03-26 2011-03-25 Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales

Country Status (12)

Country Link
US (3) US8987196B2 (es)
EP (2) EP2552242B2 (es)
CN (2) CN102892309B (es)
BR (1) BR112012024102B1 (es)
DK (2) DK2984942T3 (es)
ES (1) ES2555257T5 (es)
HU (1) HUE025633T2 (es)
MY (2) MY160552A (es)
PL (1) PL2552242T5 (es)
PT (1) PT2552242E (es)
RU (1) RU2559432C2 (es)
WO (2) WO2011119023A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201402898SA (en) * 2011-12-14 2014-07-30 Nestec Sa Methods for predicting age-or developmental stage-appropriate foods for children
CN104364259A (zh) * 2012-03-26 2015-02-18 普罗努塔利亚公司 营养性片段、蛋白质和方法
CA2868469A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
SG11201405842PA (en) 2012-03-26 2014-10-30 Pronutria Inc Charged nutritive proteins and methods
EP2831100A4 (en) * 2012-03-26 2016-02-10 Pronutria Inc NUTRIENT PROTEINS AND METHODS
BR112015011853B1 (pt) * 2012-11-23 2021-02-09 N.V. Nutricia fórmula infantil ou de acompanhamento que compreende uma composição proteinácea
JP6520712B2 (ja) 2013-09-24 2019-05-29 味の素株式会社 糖アミノ酸およびその用途
AU2014324901A1 (en) 2013-09-25 2016-05-19 Axcella Health Inc. Compositions and formulations for prevention and treatment of diabetes and obesity, and methods of production and use thereof in glucose and caloric control
RU2687038C1 (ru) 2013-11-29 2019-05-06 Нестек С.А. Соответствующие возрастным потребностям питательные композиции с различным содержанием белка
EP3082463B1 (en) 2013-11-29 2019-05-01 Nestec S.A. Use of nutritional compositions having a low protein amount
CN113331426A (zh) 2014-04-08 2021-09-03 雅培公司 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
WO2015154259A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
WO2015178762A1 (en) * 2014-05-19 2015-11-26 N.V. Nutricia Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
EP3145333B1 (en) 2014-05-19 2020-11-04 N.V. Nutricia Infant formula with optimised amino acid profiles
CN104012659B (zh) * 2014-06-26 2016-04-20 中恩（天津）营养科技有限公司 一种用于苯丙酮尿症儿童的配方粉及其制备方法
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
WO2016091265A1 (en) * 2014-12-08 2016-06-16 Glycom A/S Synthetic composition for treating metabolic disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
EP3471562A4 (en) * 2016-06-15 2020-07-29 Glycom A/S SYNTHETIC COMPOSITIONS WITH MOTHER MILK OLIGOSACCHARIDES FOR THE PREVENTION AND TREATMENT OF DISEASES
WO2018042255A2 (en) * 2016-08-31 2018-03-08 Lange Martin R Nutritional compositions and methods of using same
CN109963569A (zh) * 2016-10-05 2019-07-02 科尔生公司 用基于氨基酸的营养组合物喂养的婴儿或幼儿中肠道微生物群组成的正常化
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
DE102017200007A1 (de) 2017-01-02 2018-07-05 Schott Ag Spritze mit unterschiedlichen Materialien
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
GB2566971B (en) * 2017-09-28 2020-12-02 Mjn Us Holdings Llc Infant formula having decreased protein content
US20200319203A1 (en) * 2017-12-19 2020-10-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for fetal growth
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CN109527093A (zh) * 2018-12-27 2019-03-29 安徽康博特保健食品有限公司 一种婴幼儿营养包特殊膳食产品及其制备方法
RU2721605C1 (ru) * 2019-11-11 2020-05-21 Общество с ограниченной ответственностью "Ай Кью Витаминная студия" Фармацевтическая композиция для парентерального капельного введения
IL305376A (en) * 2021-02-24 2023-10-01 Milk Care Co Inc Milk substitutes that include human breast milk proteins
CN113092652B (zh) * 2021-03-19 2022-09-30 浙江工商大学 一种用于评估个体过敏程度的试剂盒

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697287A (en) 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
FI904074A0 (fi) * 1989-08-28 1990-08-17 Milupa Ag Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk.
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
DE4042115C2 (de) 1990-12-28 1993-11-25 Milupa Ag Phenylalaninfreie Säuglings- und Kleinkindernahrungsgrundlage und Verfahren zu ihrer Herstellung
AU679020B2 (en) 1992-12-23 1997-06-19 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
US6511696B2 (en) 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
US6503530B1 (en) * 2001-11-01 2003-01-07 Chunghee Kimberly Kang Method of preventing development of severe metabolic derangement in inborn errors of metabolism
US7651716B2 (en) * 2001-12-21 2010-01-26 Wyeth Llc Methods for reducing adverse effects of feeding formula to infants
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
WO2007022968A1 (de) * 2005-08-23 2007-03-01 Hans Leweling Proteinzusammensetzung zur behandlung von proteinmangelzuständen
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
MY152880A (en) * 2006-08-29 2014-11-28 Dsm Ip Assets Bv Use of dpa(n-6) oils in infant formula
KR20090125758A (ko) * 2007-02-28 2009-12-07 메이지 데어리즈 코포레이션 아미노산 조성물
US20100317562A1 (en) * 2007-03-23 2010-12-16 Lynn Paolella Dietary Compositions

Also Published As

Publication number Publication date
HUE025633T2 (en) 2016-04-28
MY177379A (en) 2020-09-14
RU2012145528A (ru) 2014-05-20
US10136668B2 (en) 2018-11-27
RU2559432C2 (ru) 2015-08-10
PT2552242E (pt) 2016-01-08
WO2011119033A1 (en) 2011-09-29
PL2552242T3 (pl) 2016-03-31
BR112012024102B1 (pt) 2020-01-28
EP2552242B2 (en) 2021-09-01
MY160552A (en) 2017-03-15
CN107821606A (zh) 2018-03-23
EP2552242B1 (en) 2015-09-09
CN107821606B (zh) 2021-09-14
EP2984942A1 (en) 2016-02-17
US20170181460A1 (en) 2017-06-29
EP2552242A1 (en) 2013-02-06
EP2984942B1 (en) 2020-04-22
DK2552242T3 (en) 2015-12-21
PL2552242T5 (pl) 2021-11-08
US20130079276A1 (en) 2013-03-28
CN102892309A (zh) 2013-01-23
WO2011119023A1 (en) 2011-09-29
DK2984942T3 (da) 2020-06-15
ES2555257T5 (es) 2022-02-25
US20150352178A1 (en) 2015-12-10
US8987196B2 (en) 2015-03-24
US9492498B2 (en) 2016-11-15
DK2552242T4 (da) 2021-11-01
CN102892309B (zh) 2016-01-27
BR112012024102A2 (pt) 2015-09-01

Similar Documents

Publication Publication Date Title
ES2555257T3 (es) Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales
JP2010513259A5 (es)
Wu et al. Proline and hydroxyproline metabolism: implications for animal and human nutrition
MX2013012230A (es) Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas.
RU2009126763A (ru) Лечение общих расстройств развития
US20060247313A1 (en) Amino acid composition promoting collagen synthesis
WO2008081582A1 (ja) 容器詰飲料
JP2016509994A5 (es)
CA2678807A1 (en) Compositions and methods for controlling the weight of animals
JP2011523626A5 (es)
PE20210371A1 (es) Composiciones y metodos para el tratamiento de hemoglobinopatias y talasemias
WO2010000801A3 (de) Molkenproteinhydrolysate enthaltend tryptophanhaltige peptide aus alpha-lactalbumin und deren verwendung
BR112015032572A2 (pt) composições e métodos para melhorar o desempenho durante exercícios
WO2009057775A1 (ja) アミノ酸組成物を含有する疲労防止剤
WO2020001203A1 (zh) 一种复方氨基酸维生素注射液及其应用
EP3298908A2 (en) Protein-based amino acid composition for use prior to exercise
ATE541568T1 (de) Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten
US20190216902A1 (en) Amino acid composition for collagen formation
BR112014003445A2 (pt) métodos para melhora de sintomas ou condições causadas por estresse
BR112013031496A2 (pt) composição de aminoácidos
RU2015133023A (ru) Активация адипонектина с использованием гидролизата казеина
US20210127647A1 (en) Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease
RU2010105710A (ru) Мутантная аденилатциклаза, днк, кодирующая ее, бактерия семейства enterobacteriaceae, содержащая указанную днк, и способ получения l-аминокислот
AR067788A1 (es) Proceso para la preparacion de un polipeptido para su uso farmaceutico
CL2008000520A1 (es) Composicion para suplementar la dieta de rumiantes con una fuente de aminoacidos esenciales protegida contra la accion del rumen que comprende un derivado de imina de un aminoacido esencial y un vehiculo no toxico; procedimiento para proveer lisina p